4
Changes in Ownership
Tango Therapeutics, Inc. Filed Acc 0000899243-21-033152
Options or other derivatives
- Chief Executive Officer acquired 961,403 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Weber Barbara Chief Executive Officer | 2021-08-12 | Grant or award · Stock Option (Right to Buy) | +961,403 | $9.56 | 2031-08-12 | 961,403 | 961,403 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…